Q-omics provides the consensus-scored OSTCP1 profile across patient tissues and cancer cell-line models. OSTCP1 expression is associated with patient survival in 20 of 34 cancer types, with the highest sampling consensus in OV. Among the 18 cancer types available for tumor–normal comparison, OSTCP1 is differentially expressed in 10, with the highest sampling consensus in LUAD. Additionally, OSTCP1 RNA expression shows 8,346 significant gene co-expression associations, with the highest sampling consensus in DLBC. Together, these results highlight OV, LUAD, and DLBC as cancer lineages where OSTCP1 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for OSTCP1 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes OSTCP1 survival associations across molecular data types. OSTCP1 RNA expression shows survival associations in the most cancer types (20). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible OSTCP1 RNA expression–survival associations across cancer types. High OSTCP1 expression shows unfavorable associations in OV, ACC, ESCA and CHOL, but favorable associations in READ and UCS. The OV Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .001). Together, the overview and detailed table identify OV as the clearest survival context for OSTCP1 RNA expression.
This table summarizes OSTCP1 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 10. The strongest signals are observed in LUAD for RNA.
This table ranks reproducible tumor–normal expression differences for OSTCP1. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. OSTCP1 shows higher tumor expression in LUAD, KIRC, COAD, BRCA, PAAD and HNSC. The LUAD box plot shows higher OSTCP1 RNA expression in tumor versus normal tissue (log2 FC = +0.297, t-test p < 0.001).
This table shows molecular features associated with OSTCP1 in patient tissues and cancer cell lines. In patient samples, OSTCP1 shows the broadest associations at the RNA and protein expression levels, with DLBC recurring as the lineage with the largest associated feature set. In cancer cell lines, OSTCP1 RNA and mutation anchors are most strongly linked to RNA-expression features, especially in SOFT_TISSUE.
